0001209191-19-020385.txt : 20190319 0001209191-19-020385.hdr.sgml : 20190319 20190319172220 ACCESSION NUMBER: 0001209191-19-020385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190315 FILED AS OF DATE: 20190319 DATE AS OF CHANGE: 20190319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leneghan Kathleen P. CENTRAL INDEX KEY: 0001722868 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 19692567 MAIL ADDRESS: STREET 1: ONE INVACARE WAY CITY: ELYRIA STATE: OH ZIP: 44035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-15 0 0000742112 INVACARE CORP IVC 0001722868 Leneghan Kathleen P. ONE INVACARE WAY ELYRIA OH 44035 0 1 0 0 Senior VP and CFO Common Shares 2019-03-15 4 A 0 37895 0.00 A 83311 D Common Shares 4940.87 I By Invacare Retirement Savings Plan Employee Stock Option (Right to Buy) Common Shares 41100 41100 D Phantom Stock Common Shares 358.334 358.334 D Restricted shares granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in 1/3 annual increments over three years commencing on May 15, 2020. Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2018, the most recent information reasonably available. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4 or Form 5. The reporting person holds previously reported options to buy 41,100 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 19, 2009 and March 18, 2013, at exercise prices between $13.37 to $25.24 per share, will expire between August 19, 2019 and March 18, 2023, and became exercisable between September 30, 2010 and March 31, 2017. Upon cessation of employment in accordance with the terms and conditions of the Invacare Corporation Deferred Compensation Plus Plan. Owned by Trustee for the Invacare Corporation Deferred Compensation Plus Plan. The information given is based on a Plan Statement of December 31, 2018, the most recent information reasonably available. /s/ Kathleen P. Leneghan, by Kristofer K. Spreen, her attorney-in-fact, pursuant to Power of Attorney dated November 10, 2017, on file with the Commission 2019-03-19